Indian-origin doctor charged with causing patient's death

Image
Press Trust of India Singapore
Last Updated : Oct 15 2019 | 1:50 PM IST

A 75-year-old Indian-origin doctor in Singapore is facing a criminal charge for causing the death of his patient in 2014 by allegedly prescribing medicines without conducting the necessary medical tests.

Haridass Radass, who is a general practitioner at Tekka Clinic Surgery in Little India shopping precinct, allegedly prescribed 10 tablets of methotrexate a chemotherapy agent and immune system suppressant to Savarimuthu Arul Xavier without first arranging for him to undergo the necessary tests.

The dosage was also not in line with the established guidelines, reported the Today newspaper on Tuesday, citing court documents.

The doctor, who has been in practise for 40 years, is also accused of giving the patient an injection of dexamethasone, which is an anti-inflammatory steroid.

He also allegedly prescribed 10 tablets of prednisolone, used to treat inflammation, and 10 tablets of chlorpheniramine, an antihistamine, to Xavier.

This is said to have caused the patient to develop neutropenia and mucositis, leading to a fatal invasive fungal infection.

Neutropenia occurs when a person lacks a certain type of white blood cell, which help to fight infections and mucositis is a condition when a person's mouth or gut becomes sore and inflamed a common side effect of chemotherapy for cancer.

However, the court documents did not state what kind of treatment Xavier was receiving from the doctor when he died.

The doctor was first charged in the state courts on October 4 and is out on bail of SGD10,000 (USD 7,295). He will return to court on October 29 for a pre-trial conference, the report said.

He could be jailed for up to five years, fined or both if found guilty of the crime.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 15 2019 | 1:50 PM IST

Next Story